Position in GLUE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,289,150
+$1,032,239 QoQ
Shares Held
94,593
+23.8% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 193 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. GLUE ranks #91 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in GLUE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,289,150 | 94,593 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,256,911 | 76,408 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $969,949 | 61,859 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $473,839 | 63,946 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $286,768 | 63,585 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $288,788 | 62,239 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $428,829 | 61,791 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $278,080 | 52,468 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $179,239 | 47,925 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $328,198 | 46,553 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $256,284 | 45,360 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $218,438 | 45,603 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $308,421 | 45,025 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $359,687 | 46,173 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $333,690 | 43,849 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $350,999 | 42,962 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $392,118 | 40,550 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $339,171 | 24,192 | Shares | Sole | 2022-05-12 | |
| 2021-09-30 | $205,711 | 9,233 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||